Lourdes P. Hurtado-Cordova
Victoria De Durango, DUR 34000, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oxidative DNA Damage as an Integrative Marker of Redox Dysfunction Associated with Doxorubicin-Induced Cardiotoxicity in Pediatric Leukemia.
Journal: Current issues in molecular biology
Published: May 04, 2026
Nutritional status as a risk factor for adverse events associated with L-Asparaginase in children with acute lymphoblastic leukemia.
Journal: Tumori
Published: January 16, 2026
Impact of single-nucleotide variants and individual characteristics on adverse events of L-asparaginase in children with acute lymphoblastic leukemia.
Journal: Frontiers in pharmacology
Published: April 25, 2024
Impact of single-nucleotide variants and nutritional status on population pharmacokinetics of Doxorubicin, and its effect on cardiotoxicity in children with leukemia.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: September 16, 2022
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia.
Journal: Pharmacogenetics and genomics
Published: June 07, 2021
Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population.
Journal: Frontiers in pharmacology
Published: October 12, 2020
A strategy for the clinical remission of acute lymphoblastic leukemia elicited by treatment of β-thalassemia major: A case report.
Journal: Molecular and clinical oncology
Published: September 05, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026